Dec 16, 2022
35:34
For every 34 shares held, investors received 35. The price per share adjusted from $0.09 to $0.09.
The split itself did not change the total investment value.
Shield Therapeutics Plc (OTC:SHIEF) operates in the Pharmaceuticals: major industry.
Shield Therapeutics Plc company overviewShield Therapeutics Plc's most recent stock split was on December 16, 2022. It was a 35-for-34 forward split, so shareholders received 35 shares for every 34 they held.
Shield Therapeutics Plc has split its stock once. This history records one forward split, on December 16, 2022.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Shield Therapeutics Plc's 35-for-34 split on December 16, 2022, every 34 shares became 35 shares.
Shield Therapeutics Plc has not announced a new split in our records. Its most recent split was on December 16, 2022, 3 years ago. Companies announce splits in advance, and any new OTC:SHIEF split will appear on this page.
Already premium?